{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:23:58Z","timestamp":1790843038309,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Worldwide Clinical Trials"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pnpbp.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T21:05:13Z","timestamp":1494363913000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial"],"prefix":"10.1016","volume":"78","author":[{"given":"John","family":"Sramek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Loebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Pikalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal R.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2-3","key":"10.1016\/j.pnpbp.2017.05.002_bb0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-0327(93)90025-F","article-title":"Sex differences in rates of depression: cross-national perspectives","volume":"29","author":"Weissman","year":"1993","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(99)00158-5","article-title":"Gender differences in chronic major and double depression","volume":"60","author":"Kornstein","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/7854_2010_118","article-title":"The impact of gender on antidepressants","volume":"8","author":"Sramek","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.002_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/ENDO:29:2:199","article-title":"Multiple pathways transmit neuroprotective effects of gonadal steroids","volume":"29","author":"Bryant","year":"2006","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.pnpbp.2017.05.002_bb0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0006-3223(94)00181-2","article-title":"Estrogen augments serotonergic activity in postmenopausal women","volume":"37","author":"Halbreich","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2008.07.002","article-title":"Sex differences in response to citalopram: a STAR*D report","volume":"43","author":"Young","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.jcp.0000168879.03169.ce","article-title":"Sex differences in antidepressant response in recent antidepressant clinical trials","volume":"25","author":"Khan","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.002_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v60n0802","article-title":"The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management","volume":"60","author":"Haykal","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2017.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1176\/appi.ajp.157.9.1445","article-title":"Gender differences in treatment response to sertraline versus imipramine in chronic depression","volume":"157","author":"Kornstein","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0924-977X(01)00089-X","article-title":"Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile","volume":"11","author":"Martenyi","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2017.05.002_bb0055","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4088\/JCP.v62n1106","article-title":"Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo","volume":"62","author":"Entsuah","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2017.05.002_bb0060","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1176\/appi.ajp.160.9.1643","article-title":"Danish University Antidepressant G. Are gender differences important for the clinical effects of antidepressants?","volume":"160","author":"Hildebrandt","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1017\/S0033291703007918","article-title":"Gender differences in response to differing antidepressant drug classes: two negative studies","volume":"33","author":"Parker","year":"2003","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0278-5846(03)00177-5","article-title":"Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders","volume":"28","author":"Baca","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200501000-00001","article-title":"Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline","volume":"20","author":"Thiels","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2017.05.002_bb0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/da.22328","article-title":"Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an \u201cindividual patient data\u201d meta-analysis","volume":"31","author":"Cuijpers","year":"2014","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1345\/aph.18465","article-title":"Gender differences in depression and antidepressant pharmacokinetics and adverse events","volume":"34","author":"Frackiewicz","year":"2000","journal-title":"Ann. Pharmacother."},{"issue":"Suppl. 18","key":"10.1016\/j.pnpbp.2017.05.002_bb0090","first-page":"8","article-title":"Special issues related to the treatment of depression in women","volume":"64","author":"Yonkers","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.pnpbp.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1176\/appi.ajp.159.11.1848","article-title":"Are there differences between women's and men's antidepressant responses?","volume":"159","author":"Quitkin","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2017.05.002_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000213616","article-title":"Risks of antidepressants in the elderly: tricyclic antidepressants and arrhythmia-revising risks","volume":"40","author":"Glassman","year":"1994","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.002_bb0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biopha.2008.03.010","article-title":"Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects","volume":"63","author":"Pae","year":"2009","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.jcp.0000085415.08426.c6","article-title":"A comparison of antidepressant response in younger and older women","volume":"23","author":"Grigoriadis","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1-3","key":"10.1016\/j.pnpbp.2017.05.002_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jad.2006.02.010","article-title":"Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?","volume":"93","author":"Pinto-Meza","year":"2006","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4088\/JCP.12m07841","article-title":"Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study","volume":"75","author":"Kornstein","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.002_bb0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.31887\/DCNS.2016.18.4\/ncutler","article-title":"Sex differences in the psychopharmacological treatment of depression","volume":"18","author":"Sramek","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.05.002_bb0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/WNR.0b013e328352de40","article-title":"5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux","volume":"23","author":"Huang","year":"2012","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.002_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7 receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.002_bb0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2015.15060770","article-title":"Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind, placebo-controlled study","volume":"173","author":"Suppes","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0160","series-title":"What Every Woman Needs to Know about Menopause","author":"Minkin","year":"1997"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.05.002_bb0165","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0895-4356(98)00119-X","article-title":"Prospective study of factors influencing the onset of natural menopause","volume":"51","author":"Kato","year":"1998","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.05.002_bb0170","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.002_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.socscimed.2015.03.031","article-title":"Puberty and perimenopause: reproductive transitions and their implications for women's health","volume":"132","author":"Hoyt","year":"2015","journal-title":"Soc. Sci. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.002_bb0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/S1516-31802001000200008","article-title":"The perimenopause, depressive disorders, and hormonal variability","volume":"119","author":"Soares","year":"2001","journal-title":"Sao Paulo Med. J."},{"issue":"10","key":"10.1016\/j.pnpbp.2017.05.002_bb0195","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2010.09071011","article-title":"Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication","volume":"167","author":"Angst","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.05.002_bb0200","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archgenpsychiatry.2009.158","article-title":"Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity","volume":"66","author":"Zimmermann","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2014.09.026","article-title":"The prevalence and illness characteristics of DSM-5-defined \u201cmixed feature specifier\u201d in adults with major depressive disorder and bipolar disorder: results from the International Mood Disorders Collaborative Project","volume":"172","author":"McIntyre","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"7-8","key":"10.1016\/j.pnpbp.2017.05.002_bb0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1399-5618.2011.00957.x","article-title":"Subthreshold bipolarity: diagnostic issues and challenges","volume":"13","author":"Nusslock","year":"2011","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.002_bb0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0447.2008.01324.x","article-title":"Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome","volume":"119","author":"Smith","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.002_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0889-8545(02)00007-4","article-title":"The perimenopause: definitions, demography, and physiology","volume":"29","author":"Speroff","year":"2002","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.05.002_bb0225","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1034\/j.1600-0412.2002.810706.x","article-title":"Reproductive hormones: ageing and the perimenopause","volume":"81","author":"Robertson","year":"2002","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.002_bb0230","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07399339609516246","article-title":"Perimenopause: the transition into menopause","volume":"17","author":"Li","year":"1996","journal-title":"Health Care Women Int."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.002_bb0235","first-page":"85","article-title":"The perimenopause: a critical time in a woman's life","volume":"41","author":"Sulak","year":"1996","journal-title":"Int. J. Fertil. Menopausal Stud."},{"key":"10.1016\/j.pnpbp.2017.05.002_bb0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1993.tb26342.x","article-title":"The science of reviewing research","volume":"703","author":"Oxman","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.002_bb0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00019442-199721520-00002","article-title":"Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group","volume":"5","author":"Schneider","year":"1997","journal-title":"Am. J. Geriatr. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:16:57Z","timestamp":1659007017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616303487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":49,"alternative-id":["S0278584616303487"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.002","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}